Literature DB >> 19852026

Sporadic late onset nemaline myopathy responsive to IVIg and immunotherapy.

Margherita Milone1, Amiram Katz, Anthony A Amato, Carl A Soderland, Miruna Segarceanu, Nathan P Young, H Royden Jones.   

Abstract

Sporadic late onset nemaline myopathy (SLONM) is a progressive myopathy of indeterminate etiology and poor outcome. If associated with a monoclonal gammopathy, SLONM carries a more unfavorable prognosis. Immunotherapy was unsuccessful. We report two HIV-negative SLONM/monoclonal gammopathy patients who improved following intravenous immunoglobulin (IVIg) treatment alone or in combination with immunosuppressant agents. This favorable response to treatment suggests that a dysimmune mechanism is operative in some SLONM individuals. We suggest that IVIg deserves initial consideration for SLONM therapy.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19852026     DOI： 10.1002/mus.21504

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


  11 in total

Review 1.  [Treatability of sporadic late onset nemaline myopathy].

Authors:  F Hanisch; I Schneider; T Müller; B F Romeike; G Stoltenburg; H J Holzhausen; S Zierz
Journal:  Nervenarzt       Date:  2013-08       Impact factor: 1.214

2.  Sporadic late-onset nemaline myopathy in a patient with primary Sjögren's syndrome.

Authors:  Miki Suzuki; Yuko Shimizu; Megumi Takeuchi; Masaki Kobayashi; Makoto Iwata; Shinichiro Uchiyama
Journal:  J Neurol       Date:  2011-07-12       Impact factor: 4.849

3.  Consensus statement on standard of care for congenital myopathies.

Authors:  Ching H Wang; James J Dowling; Kathryn North; Mary K Schroth; Thomas Sejersen; Frederic Shapiro; Jonathan Bellini; Hali Weiss; Marc Guillet; Kimberly Amburgey; Susan Apkon; Enrico Bertini; Carsten Bonnemann; Nigel Clarke; Anne M Connolly; Brigitte Estournet-Mathiaud; Dominic Fitzgerald; Julaine M Florence; Richard Gee; Juliana Gurgel-Giannetti; Allan M Glanzman; Brittany Hofmeister; Heinz Jungbluth; Anastassios C Koumbourlis; Nigel G Laing; Marion Main; Leslie A Morrison; Craig Munns; Kristy Rose; Pamela M Schuler; Caroline Sewry; Kari Storhaug; Mariz Vainzof; Nanci Yuan
Journal:  J Child Neurol       Date:  2012-03       Impact factor: 1.987

4.  Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort.

Authors:  Mauro Monforte; Guido Primiano; Gabriella Silvestri; Massimiliano Mirabella; Marco Luigetti; Cristina Cuccagna; Enzo Ricci; Serenella Servidei; Giorgio Tasca
Journal:  J Neurol       Date:  2018-01-22       Impact factor: 4.849

Review 5.  HIV-related neuromuscular diseases: nemaline myopathy, amyotrophic lateral sclerosis and bibrachial amyotrophic diplegia.

Authors:  L P Rowland
Journal:  Acta Myol       Date:  2011-06

Review 6.  Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases.

Authors:  Lukas J Schnitzler; Tobias Schreckenbach; Aleksandra Nadaj-Pakleza; Werner Stenzel; Elisabeth J Rushing; Philip Van Damme; Andreas Ferbert; Susanne Petri; Christian Hartmann; Antje Bornemann; Andreas Meisel; Jens A Petersen; Thomas Tousseyn; Dietmar R Thal; Jens Reimann; Peter De Jonghe; Jean-Jacques Martin; Peter Y Van den Bergh; Jörg B Schulz; Joachim Weis; Kristl G Claeys
Journal:  Orphanet J Rare Dis       Date:  2017-05-11       Impact factor: 4.123

7.  Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy.

Authors:  Rouslan Kotchetkov; Anna Dyszkiewicz-Korpanty; Vishal Kukreti
Journal:  Bone Marrow Transplant       Date:  2018-01-24       Impact factor: 5.483

8.  A case of sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance: long-term observation of neurological symptoms after autologous stem-cell transplantation.

Authors:  Takashi Ando; Takahiko Sato; Shingo Kurahashi; Yuka Kawaguchi; Yusuke Kagaya; Yukiyasu Ozawa; Satoko Hirano; Yoji Goto; Kazuo Mano; Satoshi Yokoi; Tomohiko Nakamura; Ayuka Murakami; Seiya Noda; Seigo Kimura; Jun Sone; Satoshi Kuru; Gen Sobue; Masahisa Katsuno
Journal:  Nagoya J Med Sci       Date:  2021-08       Impact factor: 1.131

9.  Impact of hematologic complete response in the treatment of sporadic late-onset nemaline myopathy associated with monoclonal gammopathy.

Authors:  Tânia Maia; Rui Bergantim; Henrique Costa; Jorge Pinheiro; Fernanda Trigo
Journal:  Clin Case Rep       Date:  2021-07-16

10.  Inflammatory features in sporadic late-onset nemaline myopathy are independent from monoclonal gammopathy.

Authors:  Jantima Tanboon; Akinori Uruha; Yukie Arahata; Carsten Dittmayer; Leonille Schweizer; Hans-Hilmar Goebel; Ichizo Nishino; Werner Stenzel
Journal:  Brain Pathol       Date:  2021-05       Impact factor: 6.508
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.